Assignee
SORRENTO THERAPEUTICS INC
US·108 granted patents·70 pending applications·255 citations·filing 2012–2024
Top patents by PatentIndex Score
178 records- 0197US10058609B2Antigen binding proteins that bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2017·Granted Aug 28, 2018·17 cites·14 claims
- 0295US12084503B2Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2) and methods of use thereof for treatmentSORRENTO THERAPEUTICS INC·Filed 2021·Granted Sep 10, 2024·2 cites·18 claims
- 0394US10213588B2Transdermal delivery of high viscosity bioactive agentsSORRENTO THERAPEUTICS INC·Filed 2017·Granted Feb 26, 2019·5 cites·37 claims
- 0494US10118963B2Antigen binding proteins that bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2017·Granted Nov 6, 2018·12 cites·17 claims
- 0594US10100118B2Antibody therapeutics that bind CD123SORRENTO THERAPEUTICS INC·Filed 2016·Granted Oct 16, 2018·6 cites·32 claims
- 0692US11247033B2Transdermal drug delivery apparatus and methodsSORRENTO THERAPEUTICS INC·Filed 2019·Granted Feb 15, 2022·10 cites·18 claims
- 0792US10940085B2Cartridge portion of transdermal drug delivery apparatus and methodsSORRENTO THERAPEUTICS INC·Filed 2018·Granted Mar 9, 2021·10 cites·14 claims
- 0892US10800852B2Antibody therapeutics that bind CD38SORRENTO THERAPEUTICS INC·Filed 2018·Granted Oct 13, 2020·3 cites·20 claims
- 0992US9676853B2Antigen binding proteins that bind PD-1SORRENTO THERAPEUTICS INC·Filed 2014·Granted Jun 13, 2017·15 cites·20 claims
- 1091US10590165B2Antibody drug conjugatesSORRENTO THERAPEUTICS INC·Filed 2016·Granted Mar 17, 2020·7 cites·14 claims
- 1191US10377827B2Antigen binding proteins that bind c-metSORRENTO THERAPEUTICS INC·Filed 2013·Granted Aug 13, 2019·14 cites·6 claims
- 1291US10233251B2Antibody therapeutics that bind CD137SORRENTO THERAPEUTICS INC·Filed 2016·Granted Mar 19, 2019·7 cites·19 claims
- 1391US10232160B2Transdermal drug delivery apparatus and methodsSORRENTO THERAPEUTICS INC·Filed 2015·Granted Mar 19, 2019·10 cites·30 claims
- 1491US10111807B2Cartridge portion of transdermal drug delivery apparatus and methodsSORRENTO THERAPEUTICS INC·Filed 2015·Granted Oct 30, 2018·10 cites·28 claims
- 1590US10953211B2Transdermal drug delivery deviceSORRENTO THERAPEUTICS INC·Filed 2018·Granted Mar 23, 2021·10 cites·18 claims
- 1690US10059774B2Antibody therapeutics that bind CD38SORRENTO THERAPEUTICS INC·Filed 2016·Granted Aug 28, 2018·6 cites·22 claims
- 1789US11142579B2Variant antibodies that bind OX40SORRENTO THERAPEUTICS INC·Filed 2018·Granted Oct 12, 2021·3 cites·19 claims
- 1889US11040183B2Receptacle portion of transdermal drug delivery apparatus and methodsSORRENTO THERAPEUTICS INC·Filed 2015·Granted Jun 22, 2021·10 cites·24 claims
- 1989US10328248B2Controller portion of transdermal drug delivery apparatus and methodsSORRENTO THERAPEUTICS INC·Filed 2015·Granted Jun 25, 2019·10 cites·23 claims
- 2089US10035855B2Antibody therapeutics that bind CD47SORRENTO THERAPEUTICS INC·Filed 2016·Granted Jul 31, 2018·8 cites·15 claims
- 2188US10919964B2Antigen binding proteins that bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2018·Granted Feb 16, 2021·2 cites·16 claims
- 2287US11180568B2Antibody therapeutics that bind CD137SORRENTO THERAPEUTICS INC·Filed 2019·Granted Nov 23, 2021·3 cites·19 claims
- 2387US10934361B2Antibody therapeutics that bind CD123SORRENTO THERAPEUTICS INC·Filed 2018·Granted Mar 2, 2021·2 cites·14 claims
- 2487US10806914B2Composite microneedle array including nanostructures thereonSORRENTO THERAPEUTICS INC·Filed 2018·Granted Oct 20, 2020·3 cites·14 claims
- 2587US10301395B2Chemically-locked bispecific antibodiesSORRENTO THERAPEUTICS INC·Filed 2016·Granted May 28, 2019·3 cites·14 claims
- 2686US9902772B2Antibody therapeutics that bind LAG3SORRENTO THERAPEUTICS INC·Filed 2016·Granted Feb 27, 2018·5 cites·10 claims
- 2785US11135414B2Medical devices for delivery of siRNASORRENTO THERAPEUTICS INC·Filed 2018·Granted Oct 5, 2021·1 cites·18 claims
- 2884US11179555B2Nanopatterned medical device with enhanced cellular interactionSORRENTO THERAPEUTICS INC·Filed 2019·Granted Nov 23, 2021·2 cites·20 claims
- 2984US11174314B2Anti-KRAS binding proteinsSORRENTO THERAPEUTICS INC·Filed 2019·Granted Nov 16, 2021·2 cites·20 claims
- 3084US10737082B2Methods for lymphatic delivery of active agentsSORRENTO THERAPEUTICS INC·Filed 2016·Granted Aug 11, 2020·4 cites·9 claims
- 3182US11129975B2Transdermal delivery of high viscosity bioactive agentsSORRENTO THERAPEUTICS INC·Filed 2019·Granted Sep 28, 2021·2 cites·10 claims
- 3282US10709884B2Device for delivery of rheumatoid arthritis medicationSORRENTO THERAPEUTICS INC·Filed 2018·Granted Jul 14, 2020·2 cites·14 claims
- 3382US10519245B2Antibodies which bind insulin-like growth factor receptor-1 (IGF1R) and methods of use thereof to treat cancerSORRENTO THERAPEUTICS INC·Filed 2013·Granted Dec 31, 2019·6 cites·12 claims
- 3482US9951144B2Antibody therapeutics that bind CD38SORRENTO THERAPEUTICS INC·Filed 2016·Granted Apr 24, 2018·2 cites·4 claims
- 3581US12017031B2Nanopatterned medical device with enhanced cellular interactionSORRENTO THERAPEUTICS INC·Filed 2021·Granted Jun 25, 2024·0 cites·20 claims
- 3679US11760806B2CD-38 directed chimeric antigen receptor constructsSORRENTO THERAPEUTICS INC·Filed 2018·Granted Sep 19, 2023·2 cites·18 claims
- 3779US11155623B2Antibody therapeutics that bind CTLA4SORRENTO THERAPEUTICS INC·Filed 2019·Granted Oct 26, 2021·1 cites·8 claims
- 3879US10342965B2Method for increasing the permeability of an epithelial barrierSORRENTO THERAPEUTICS INC·Filed 2017·Granted Jul 9, 2019·2 cites·24 claims
- 3979US9315579B2Antigen binding proteins that bind CCR2SORRENTO THERAPEUTICS INC·Filed 2013·Granted Apr 19, 2016·3 cites·8 claims
- 4079US2024238570A1Methods for better delivery of active agents to tumorsSORRENTO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4179US2024181235A1Methods for lymphatic delivery of active agentsSORRENTO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4278US10806913B2Methods for better delivery of active agents to tumorsSORRENTO THERAPEUTICS INC·Filed 2016·Granted Oct 20, 2020·2 cites·14 claims
- 4378US10435476B2Antibody therapeutics that bind JAG1SORRENTO THERAPEUTICS INC·Filed 2016·Granted Oct 8, 2019·4 cites·5 claims
- 4478US2023137871A1Device for delivery of rheumatoid arthritis medicationSORRENTO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4577US11878058B2Antigen binding proteins that bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2021·Granted Jan 23, 2024·0 cites·19 claims
- 4677US11013816B2Antibody drug conjugates having derivatives of amatoxin as the drugSORRENTO THERAPEUTICS INC·Filed 2017·Granted May 25, 2021·1 cites·17 claims
- 4777US10584168B2Antigen binding proteins that bind PD-1SORRENTO THERAPEUTICS INC·Filed 2017·Granted Mar 10, 2020·1 cites·7 claims
- 4875US11746156B2Antibody therapeutics that bind CD123SORRENTO THERAPEUTICS INC·Filed 2021·Granted Sep 5, 2023·0 cites·14 claims
- 4975US11235101B2Fluid delivery apparatus having a gas extraction device and method of useSORRENTO THERAPEUTICS INC·Filed 2020·Granted Feb 1, 2022·0 cites·20 claims
- 5075US10202453B2Antibody therapeutics that bind CTLA4SORRENTO THERAPEUTICS INC·Filed 2016·Granted Feb 12, 2019·1 cites·15 claims
Showing the top 50 of 178 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →